Author

Kimberly A. Parkerson

Observed names: Kimberly Parkerson, Parkerson, Kimberly A.

Institution: Stoke Therapeutics, Inc. (United States)

Observed institutions: Brigham and Women's Hospital, Tufts Medical Center, Biogen (United States), Harvard University, Civitan International, University of Alabama at Birmingham, Stoke Therapeutics, Inc. (United States)

ORCID: 0000-0003-4051-0999

Observed ORCID: 0000-0003-4051-0999

OpenAlex ID: A5036858833

Biophysical and pharmacological characterization of hypotonically activated chloride currents in cortical astrocytes

2004 · Kimberly A. Parkerson, Harald Sontheimer · Glia · 66

Contribution of chloride channels to volume regulation of cortical astrocytes

2003 · Kimberly A. Parkerson, Harald Sontheimer · American Journal of Physiology-Cell Physiology · 50

Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)

2023 · Jorrit Tjeertes, Carlos A. Bacino, et al. · Journal of Neurodevelopmental Disorders · 28

Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients

2010 · Kimberly A. Parkerson, Claus Reinsberger, et al. · Epilepsy & Behavior · 27

Zorevunersen in Children and Adolescents with Dravet Syndrome

2026 · Linda Laux, Joseph Sullivan, et al. · New England Journal of Medicine · 25

Adaptive functioning and neurodevelopment in patients with Dravet syndrome: 12-month interim analysis of the BUTTERFLY observational study

2024 · Joseph Sullivan, Elaine Wirrell, et al. · Epilepsy & Behavior · 21

Qualitative evaluation of meaningful change in Dravet syndrome as measured by the Vineland-3: Caregiver and clinician perspectives

2025 · Carolyn Condon, Kimberly A. Parkerson, et al. · Epilepsy & Behavior · 15

Interim results of adaptive functioning and neurodevelopment in BUTTERFLY – An observational study of children and adolescents with Dravet syndrome

2022 · Joseph Sullivan, Elaine Wirrell, et al. · Epilepsy & Behavior · 11

Use of an electronic seizure diary in a randomized, controlled trial of natalizumab in adult participants with drug-resistant focal epilepsy

2021 · Jagdish Patel, Wei Feng, et al. · Epilepsy & Behavior · 11

Natural History of Children and Adolescents With Dravet Syndrome

2025 · Joseph Sullivan, Elaine C. Wirrell, et al. · Neurology · 9

Electrophysiological Improvements in Patients with Dravet Syndrome Following Treatment with Zorevunersen, an Investigational Antisense Oligonucleotide (S19.001)

2026 · Nigel Colenbier, Caroline Neuray, et al. · Neurology

Zorevunersen Demonstrates Potential as a Disease-modifying Therapy in Patients with Dravet Syndrome Through Durable Seizure Reduction and Improvements in Cognition, Behavior, and Quality of Life Through 36 Months of Treatment in Open-label Extension Studies (S19.007)

2026 · Linda Laux, Kelly G. Knupp, et al. · Neurology

How Much Propofol Treats Status Epilepticus ? (782)

2020 · Joel Oster, Kimberly Parkerson, et al. · Neurology

Specialized channels in astrocytes

2004 · Kimberly A. Parkerson, Harald Sontheimer · Springer eBooks

Works count: 16

Citation count: 262

H-index: 9

I10-index: 9